Peter Altman - 23 Apr 2025 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
President and CEO, Director
Signature
/s/ David McClung, by power of attorney
Issuer symbol
BCDA
Transactions as of
23 Apr 2025
Transactions value $
$49,999
Form type
4
Filing time
25 Apr 2025, 21:35:23 UTC
Previous filing
17 Apr 2025
Next filing
16 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Purchase $50K +26.2K +23.28% $1.91 139K 23 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA Warrant (right to buy) Purchase +26.2K +57.98% 71.5K 23 Apr 2025 Common Stock 26.2K $1.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased.